Dagmar
Dagmar Antoni-Zimmermann, Speyer DE
Patent application number | Description | Published |
---|---|---|
20080305137 | Coating material with biocide microcapsules - The invention relates to a coating material for protection against microorganism invasion on surfaces which are exposed to the effects of damp or water. The coating material has either a pH-value of at least 11.0 or is provide with a base material for the coating whereby the pH-value is at least 11. The coating material is characterized in that it contains a biocide which bonds to solid particles in a carrier material and is released in a delayed manner therefrom. | 12-11-2008 |
20090156570 | Synergistic biocide composition comprising 2-methylisothiazoline-3-one - A biocide composition, comprising 2-methylisothiazolin-3-one as a biocidal active ingredient and at least one further biocidal active ingredient, as an additive to materials capable of being attacked by harmful microorganisms, wherein the composition comprises a pyrithione as the further biocidal active ingredient. | 06-18-2009 |
Dagmar Becker, Ostringen DE
Patent application number | Description | Published |
---|---|---|
20120078976 | DATA ORGANIZATION TOOL AND APPARATUS FOR REMOTELY MANAGING A MEETING - The system, method and computer readable medium that facilitates selection of a meeting participant, and the creation of a first data structure based on the selected meeting participant. Data may be collected in response to the selection of the meeting participant. A second data structure may be generated for the collected data, and the data in the second data structure may be linked to the first data structure and the selected meeting participant. | 03-29-2012 |
Dagmar Boltersdorf, Kreuzau DE
Patent application number | Description | Published |
---|---|---|
20090149941 | Compressible tubular tissue supports - The invention provides a novel compressed tubular tissue supports ( | 06-11-2009 |
Dagmar Bonhage, Wennigsen DE
Patent application number | Description | Published |
---|---|---|
20110244220 | Metals parts containing a protective coating - Metal parts, especially parts made from aluminium, aluminium alloys, steel and stainless steel, are described which comprise a coating containing TiOF | 10-06-2011 |
Dagmar Braun, Greifswald - Insel Riems DE
Patent application number | Description | Published |
---|---|---|
20080254068 | Novel Vaccine for Veterinary and Human Medicine Prophylaxis and Therapy - The present invention relates to a novel vaccine, its use for immunoprophylaxis and/or the treatment of candidamycoses in human and veterinary medicine as well as methods for its preparation, wherein said vaccine consists of the combination of the | 10-16-2008 |
Dagmar Brockschnieder, Rietberg DE
Patent application number | Description | Published |
---|---|---|
20100176647 | Slide Fastener Element, Cushion Arrangement and Vehicle Seat - A slide fastener element, cushion arrangement, vehicle seat or interior covering part. The slide fastener element includes a flexible, foamable lattice that is provided with a plurality of holes, and a plurality of slide fastener teeth secured directly to the lattice. | 07-15-2010 |
Dagmar Cozikova, Temice CZ
Patent application number | Description | Published |
---|---|---|
20150320873 | C6-C18-Acylated Derivative of Hyaluronic Acid, Method of Preparation Thereof, Nanomicellar Composition on its Basis, Method of Preparation Thereof and Method of Preparation Stabilized Nanomicellar Composition, and Use Thereof - The invention relates to a method of preparation hydrophobized hyaluronic acid (Formula I) and further to a method of encapsulating biologically active substances into the nanomicelles of hydrophobized hyaluronan serving as carriers of biologically active hydrophobic substances. The hydrophobization of hyaluronan is carried out through an esterification reaction of hyaluronan with long-chain carboxylic acids, the latter being activated by a halogenide derivative of 2,4,6-trichlorobenzoic acid or by another organic chloride. In an aqueous environment, water-soluble hydrophobized derivatives can form nanomicelles in which nonpolar substances can be bound by means of non-covalent physical interactions. The core of a nanomicelle is formed by hydrophobic acyl functional groups while the shell of a nanomicelle is formed by hyaluronic acid. The encapsulation of the substances into nanomicelles can be performed by means of the solvent exchange method or by means of sonication. Hyaluronic nanomicelles support the penetration of bound substances in topical applications and enable the bound substances to be transferred into the individual cells. The nanomicelles obtained from hydrophobized hyaluronan derivatives are usable in cosmetic and pharmaceutical applications. | 11-12-2015 |
Dagmar Dassonville, Charnoz FR
Patent application number | Description | Published |
---|---|---|
20090001122 | Buttress and surgical stapling apparatus - Multilayer structures including a porous layer and a non-porous layer are useful as buttresses when associated with a surgical stapling apparatus. | 01-01-2009 |
20090004455 | Reinforced composite implant - Multilayer structures including a porous layer and a non-porous layer having a reinforcement member are useful as implants. | 01-01-2009 |
20100015868 | REINFORCED COMPOSITE IMPLANT - Multilayer structures including a porous layer and a non-porous layer having a reinforcement member are useful as implants. | 01-21-2010 |
20120031950 | Buttress and Surgical Stapling Apparatus - Multilayer structures including a porous layer and a non-porous layer are useful as buttresses when associated with a surgical stapling apparatus. | 02-09-2012 |
20130310873 | BUTTRESS AND SURGICAL STAPLING APPARATUS - Multilayer structures including a porous layer and a non-porous layer are useful as buttresses when associated with a surgical stapling apparatus. | 11-21-2013 |
20140158742 | BUTTRESS AND SURGICAL STAPLING APPARATUS - Multilayer structures including a porous layer and a non-porous layer are useful as buttresses when associated with a surgical stapling apparatus. | 06-12-2014 |
Dagmar Destreel, Hasselt BE
Patent application number | Description | Published |
---|---|---|
20130298711 | IDLER GEAR ASSEMBLY - An idler gear assembly has a compound gear consisting of two gear wheels. The gear wheels are provided with a through bore in which a thin walled bushing is press-fitted. An additional axial fixation element is provided to fixate the bushing into the bore in axial direction. The additional axial fixation element is constituted by a circular radial outward deformation of the wall of the bushing and a circular groove provided in the internal surface of the bore in which the radial outward deformation is located. | 11-14-2013 |
Dagmar Dirnbauer, Braz AT
Patent application number | Description | Published |
---|---|---|
20080220640 | Plug-type connector with sleeve-type plug and socket - A plug-type connector has a plug-type socket, a contact holder fittable in the plug-type socket, and a cover shell engaged around the contact holder and fittable with the plug-type socket. Latch formations on the cover shell and on the contact holder secure the holder and shell together in a prelatched position with the holder only partially fitted in the shell. Thus, when the holder is fitted in the socket, the shell is to the socket and the holder is shifted in the shell into a final position fully inserted in the shell. | 09-11-2008 |
Dagmar Ehrnhofer, Vancouver CA
Patent application number | Description | Published |
---|---|---|
20090117040 | Novel pharmaceutical and diagnostic compositions for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases - The present invention relates to pharmaceutical and diagnostic compositions as well as to the use of the active substances contained therein for preparing a pharmaceutical or a diagnostic composition for the treatment or diagnosis of neurodegenerative disorders or amyloid diseases. | 05-07-2009 |
Dagmar Fischer, Marburg DE
Patent application number | Description | Published |
---|---|---|
20110306656 | Biologically tolerated low molecular weight polyethylenimines - The invention relates to low molecular weight polyethylenimines, to vectors for inserting nucleic acids into cells which contain low molecular weight polyethylenimines, and to the preparation and use of the low molecular weight polyethylenimine and the vector. | 12-15-2011 |
Dagmar Fischer, Jena DE
Patent application number | Description | Published |
---|---|---|
20140284522 | METHOD FOR GENERATING DRIED CELLULOSE AND CELLULOSE-CONTAINING MATERIAL, AND RESWELLABLE CELLULOSE PRODUCTS PRODUCED BY THIS METHOD - The aim of the invention is to dry cellulose and cellulose-containing materials in the shortest possible time and with the lowest possible technical costs, without disruptive stress on the cellulose and without loss of stability and efficacy of any additive substances, for example medicaments, and to reswell it as required almost completely to the original structure and consistency. According to the invention for the purpose of drying and obtaining the swellability with almost complete reconstitution of the cellulose structure and consistency the dried cellulose to be prepared or the cellulose-containing material is subjected to the adsorbent effect of a moisture binder, in particular an osmotically and/or hygroscopically effective solution and then dried regardless of any structural change to the material. | 09-25-2014 |
Dagmar Fischer, Regensburg DE
Patent application number | Description | Published |
---|---|---|
20110136893 | OLIGONUCLEOTIDE-, PROTEIN AND/OR PEPTIDE-POLYMER CONJUGATES - A conjugate or compound comprising polyethyleneglycol and an oligonucleotide, wherein at least one polyethyleneglycol is linked to the 5′-end of the oligonucleotide and at least one polyethyleneglycol is linked to the 3′-end of the oligonucleotide, wherein the molecular weight of the polyethyleneglycol linked to the 5′- and 3′-end of the oligonucleotide is identical and is <5000 Da, or wherein the molecular weight of the polyethyleneglycol linked to the 5′- and 3′-end of the oligonucleotide is different. | 06-09-2011 |
Dagmar Fitz-Kramer US
Patent application number | Description | Published |
---|---|---|
20140322548 | AQUEOUS SOLUTION - The invention relates to an aqueous solution containing at least one modification agent, whey, water glass and a solvent, in particular an aqueous solvent, and to the uses thereof, particularly as a fire-retardant impregnation, coating or sealant material. | 10-30-2014 |
Dagmar Gerthsen, Karlsruhe DE
Patent application number | Description | Published |
---|---|---|
20100065741 | Method For The Production Of Multiplayer Electrostatic Lens Array - The invention relates to a method for the production of a multilayer electrostatic lens arrangement with at least one lens electrode in general, a method for the production of a phase plate in particular as well as the lens arrangement, the phase plate and a transmission electron microscope with the phase plate. | 03-18-2010 |
Dagmar Hockner, Ebreichsdorf AT
Patent application number | Description | Published |
---|---|---|
20080223482 | Safety Device to Prevent Overfilling - The invention relates to a device for preventing overfilling of a plurality of fuel tanks ( | 09-18-2008 |
Dagmar Hoeltje, Gehrden DE
Patent application number | Description | Published |
---|---|---|
20100203132 | Pharmaceutical Compositions Comprising NEP-Inhibitors, Inhibitors of the Endogenous Endothelin Producing System and AT1 Receptor Antagonists - A combination therapy for cardiovascular diseases, in particular essential hypertension, pulmonary hypertension and/or congestive heart failure, involving administering a synergistic combination of at least one inhibitor of neutral endopeptidase, at least one inhibitor of the endogenous endothelin producing system, and at least one AT | 08-12-2010 |
Dagmar Kaulartz, Stolberg DE
Patent application number | Description | Published |
---|---|---|
20090076086 | SUBSTITUTED NICOTINAMIDE COMPOUNDS AND USES THEREOF - Substituted nicotinamide compounds corresponding to formula I | 03-19-2009 |
20120220627 | Substituted 2-amino-quinoline-3-carboxamides as KCNQ2/3 modulators - The invention relates to substituted 2-amino-quinoline-3-carboxamides, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders. | 08-30-2012 |
Dagmar Klass, Darmstadt DE
Patent application number | Description | Published |
---|---|---|
20120182200 | COMPONENTS FOR HIGH-FREQUENCY TECHNOLOGY, AND LIQUID-CRYSTALLINE MEDIA - The present invention relates to a component for high-frequency technology or for the microwave range and millimetre wave range of the electromagnetic spectrum, characterised in that it contains a liquid-crystal compound of the formula I | 07-19-2012 |
20130292608 | LIQUID-CRYSTALLINE MEDIA, COMPONENTS FOR HIGH-FREQUENCY TECHNOLOGY, AND MESOGENIC COMPOUNDS - The present invention relates to a liquid-crystal medium which comprises a component A which consists of one or more compounds of the formula I | 11-07-2013 |
20140021405 | MESOGENIC COMPOUNDS, LIQUID-CRYSTALLINE MEDIA AND COMPONENTS FOR HIGH-FREQUENCY TECHNOLOGY - The present invention relates to a liquid-crystal medium which comprises a component A which consists of one or more compounds of the formula IA (IA), in which the parameters have the respective meanings given in the claims or in the text, and to the corresponding, novel mesogenic compounds and to the preparation thereof. The present invention likewise relates to the use of these liquid-crystal media, in particular in components for high-frequency technology, and to components of this type which contain the media according to the invention, and to the production and use of these components. The components according to the invention are suitable, in particular, for phase shifters in the microwave and millimetre wave region, for microwave and millimetre wave array antennae and very particularly for so-called tuneable “reflectarrays”. | 01-23-2014 |
20140021409 | MESOGENIC COMPOUNDS, LIQUID-CRYSTALLINE MEDIA AND COMPONENTS FOR HIGH-FREQUENCY TECHNOLOGY - The present invention relates to a liquid-crystal medium which comprises a component A which consists of one or more compounds of the formula X | 01-23-2014 |
20140217325 | LIQUID-CRYSTALLINE MEDIUM AND HIGH-FREQUENCY COMPONENTS COMPRISING SAME - The present invention relates to liquid-crystalline media and to high-frequency components comprising same, especially microwave components for high-frequency devices, such as devices for shifting the phase of microwaves, in particular for microwave phased-array antennas. | 08-07-2014 |
20140239227 | LIQUID CRYSTAL MEDIUM AND HIGH-FREQUENCY COMPONENTS COMPRISING SAME - The present invention relates to liquid crystal media and to high-frequency components comprising same, especially microwave components for high-frequency devices, such as devices for shifting the phase of microwaves, in particular for microwave phased-array antennas. | 08-28-2014 |
20150014584 | LIQUID CRYSTAL MEDIUM AND HIGH FREQUENCY COMPONENTS COMPRISING SAME - The present invention relates to liquid crystal media and to high frequency components comprising same, especially microwave components for high-frequency devices, such as devices for shifting the phase of microwaves. | 01-15-2015 |
20150322344 | LIQUID-CRYSTALLINE MEDIA, COMPONENTS FOR HIGH-FREQUENCY TECHNOLOGY, AND MESOGENIC COMPOUNDS - The present invention relates to a liquid-crystal medium which comprises a component A which consists of one or more compounds selected from the group of the formulae I-M and I-U | 11-12-2015 |
20160002533 | LIQUID-CRYSTALLINE MEDIA, COMPONENTS FOR HIGH-FREQUENCY TECHNOLOGY, AND MESOGENIC COMPOUNDS - The present invention relates to a liquid-crystal medium which comprises a component A which consists of one or more compounds of the formula I | 01-07-2016 |
20160040066 | LIQUID-CRYSTALLINE MEDIUM AND HIGH-FREQUENCY COMPONENTS COMPRISING SAME - The present invention relates to liquid-crystalline media comprising | 02-11-2016 |
Dagmar Klein, Ockenheim DE
Patent application number | Description | Published |
---|---|---|
20100120946 | Mitsubishi polyester film GmbH - The invention relates to biaxially oriented polyester films which contain 0.1-5.0% by weight (based on the weight of the film) of a hydrolysis stabilizer based on epoxidized fatty acid esters and 0.2-10% by weight (based on the weight of the film) of epoxidized fatty acid glycerides, the epoxidized fatty acid esters having a mean molecular weight of at least 425 g/mol. Such films find use in outdoor applications, as a ribbon cable, as a backside laminate of solar modules and in electrical insulation applications. | 05-13-2010 |
20100120947 | Biaxially stretched polyester film which comprises a chain extender, and process for production thereof and use thereof - The invention relates to biaxially oriented polyester films that include a chain extender in addition to polyester. Such films find use in all applications typical of biaxially oriented polyester films, especially in outdoor applications, as a ribbon cable, as a backside laminate of solar modules and in electrical insulation applications. | 05-13-2010 |
20100292375 | Biaxially stretched polymer film comprising a decarboxylation catalyst, its use in electrical insulation applications, and process for its production - Biaxially stretched film with polymeric constituents formed mainly of polyester in which the film includes at least one copper salt and one halide, with the resulting film having an AC (alternating current) dielectric strength of at least 100 kV/mm at 23° C. and 50 Hz. The invention further relates to the use of the film of the invention, in particular in solar modules, and also to a process for its production. | 11-18-2010 |
20120184644 | Biaxially stretched polyester film which comprises a chain extender, and process for production thereof and use thereof - The invention relates to biaxially oriented polyester films that include a chain extender in addition to the polyester. Such films find use in all applications typical of biaxially oriented polyester films, especially in outdoor films, as a ribbon cable, as a backside laminate of solar modules and in electrical insulation applications. | 07-19-2012 |
20120196112 | Electrical insulation incorporating a biaxially oriented polyester film with a high portion of cyclohexanedimethanol and a primary and secondary dicarboxylic acid portion - The invention relates to electrical insulation films incorporating biaxially oriented film predominantly formed from polyester. The polyester has a diol component that includes at least 80 mol-% of 1,4-cyclohexanedimethanol (CHDM) and a dicarboxylic acid component containing at least 80 mol-% of one or more benzenedicarboxylic acid(s) and/or one or more naphthalene dicarboxylic acid(s). The dicarboxylic acid component includes a main dicarboxylic acid component forming an at least 55 mol-% portion, chosen from either 2,6-naphthalene dicarboxylic acid or terephthalic acid. The dicarboxylic acid component further includes a secondary dicarboxylic acid component, present in an amount of at least 5 mol-%, with the secondary dicarboxylic acid component differing from the main dicarboxylic acid component. The invention further relates to a method for producing the film and its use. | 08-02-2012 |
Dagmar Koppler, Rothenburg O.d. DE
Patent application number | Description | Published |
---|---|---|
20090197107 | Thermoplastic Product and Method for the Production of a Composite Product - A composite thermoplastic product includes a first polar engineering thermoplastic cohesively bonded to a second thermoplastic. The first thermoplastic can contain a polar thermoplastic polymer cohesively bonded to the second thermoplastic. The second thermoplastic can contain a styrene-based thermoplastic elastomer and a polyolefin. Methods for the production of the composite product include methods for forming an adhesive bond between polar engineering thermoplastics such as ABS, ABS/PC, PC or PMMA and non-polar thermoplastic elastomers containing styrene elastomers, such as SEBS or SEPS, combined with a polyolefin polymer. | 08-06-2009 |
Dagmar Koppler US
Patent application number | Description | Published |
---|---|---|
20110281128 | Thermoplastic Product and Method for the Production of a Composite Product - The disclosure relates to a composite thermoplastic product including a first polar engineering thermoplastic cohesively bound to a second thermoplastic that includes a styrene-based thermoplastic elastomer and a polyolefin. The first thermoplastic can contain a polar thermoplastic polymer cohesively bound to the second thermoplastic. Methods for the production of the composite product are also described, including methods for forming an adhesive bond between polar engineering thermoplastics such as ABS, ABS/PC, PC or PMMA and non-polar thermoplastic elastomers containing styrene elastomers, such as SEBS or SEPS, combined with a polyolefin polymer. | 11-17-2011 |
Dagmar Koukalova, Olomouc CZ
Patent application number | Description | Published |
---|---|---|
20080254068 | Novel Vaccine for Veterinary and Human Medicine Prophylaxis and Therapy - The present invention relates to a novel vaccine, its use for immunoprophylaxis and/or the treatment of candidamycoses in human and veterinary medicine as well as methods for its preparation, wherein said vaccine consists of the combination of the | 10-16-2008 |
Dagmar Kubitza, Ratingen DE
Patent application number | Description | Published |
---|---|---|
20090004265 | Prevention and Treatment of Thromboembolic Disorders - The present invention relates to the field of blood coagulation, more specifically it relates to a method of treating a thromboembolic disorder by administering once daily a direct factor Xa inhibitor in oral dosage form to a patient in need thereof, wherein the factor Xa inhibitor has a plasma concentration half life indicative of a bid or tid administration interval, e.g. of 10 hours or less. | 01-01-2009 |
20110003804 | Oxazolidinones For the Treatment and/or Prophylaxis of Heart Failure - The present invention relates to the use of selective inhibitors of coagulation factor Xa, in particular of oxazolidinones of the formula (I), for the treatment and/or prophylaxis of heart failure and/or disorders related to heart failure as well as their use for the preparation of pharmaceutical drugs for the treatment and/or prophylaxis of heart failure and/or disorders related to heart failure. | 01-06-2011 |
Dagmar Lambrü, Fassberg DE
Patent application number | Description | Published |
---|---|---|
20090325186 | Method for detecting analytes in a sample - The present invention relates to a method for detecting analytes in a sample comprising the steps of | 12-31-2009 |
20110105348 | Method for detecting an analyte in a sample - The present invention relates to a method for detecting an analyte in a sample comprising the steps of | 05-05-2011 |
Dagmar Lambrü, Fassberg DE
Patent application number | Description | Published |
---|---|---|
20090325186 | Method for detecting analytes in a sample - The present invention relates to a method for detecting analytes in a sample comprising the steps of | 12-31-2009 |
20110105348 | Method for detecting an analyte in a sample - The present invention relates to a method for detecting an analyte in a sample comprising the steps of | 05-05-2011 |
Dagmar Lorenz, Schwabach DE
Patent application number | Description | Published |
---|---|---|
20150284867 | DEVICE AND A METHOD FOR AN ELECTROLYTIC COATING OF AN OBJECT - A device for electrolytically coating an object is disclosed. In one aspect, the device includes an electrolyte container containing an electrolyte and a first DC power source. The device also includes at least one soluble anode which is at least partly immersed into the electrolyte and electrically conductive connected to a positive pole of the first DC power source. The device also includes at least one cathode terminal which is electrically conductive connected to a negative pole of the first DC power source and to which the object is electrically conductive connected, the object being immersed into the electrolyte. The device further includes a second DC power source configured to operate independently of the first DC power source and at least one insoluble anode, which is at least partly immersed into the electrolyte and electrically conductive connected to a positive pole of the second DC power source. | 10-08-2015 |
Dagmar Matoulkova, Trutnov CZ
Patent application number | Description | Published |
---|---|---|
20110256584 | CULTURE MEDIUM FOR CULTIVATION AND IDENTIFICATION OF BACTERIA OF GENUS PECTINATUS AND METHOD FOR TAKING SWAB SAMPLES - The present disclosure relates to a culture medium for cultivation and identification of bacteria of genus | 10-20-2011 |
Dagmar Mayer, Beilstein DE
Patent application number | Description | Published |
---|---|---|
20100088137 | WORK LISTS AND COCKPIT TO CONTROL COMPLEX PROCESSES - A method, system and article of manufacture for creating a worklist and organizing a cockpit to control complex processes execution. A process hierarchy is created, including a plurality of organizational levels. A worklist of a plurality of worktasks, grouped in accordance with the process hierarchy, is created. The plurality of worktasks includes both internal worktasks, to be executed on a local computer system, and external worktasks, to be executed on external computer systems. A number of worklist views are displayed, where each worklist view includes a corresponding subset of the plurality of worktasks organized in accordance with the process hierarchy. Executions of internal and external worktasks are initiated from one or more of the worklist. Further, detailed information relevant to the execution is received. The executions of the tasks are monitored on one the worklist views. | 04-08-2010 |
Dagmar Peters-Groth, Aachen DE
Patent application number | Description | Published |
---|---|---|
20110245106 | Sample Carrier and Method for Achieving Comparable Analytical Results By Aligning Test Substances on a Uniform Plane - A sample carrier such as a multi-well platform with one or more recesses, in each of which a substance to be analyzed is disposed, and an analysis method in which one or more substances, each of which is located in a recess of the sample carrier, are aligned on a uniform plane relative to the surface of the sample carrier before being analyzed. | 10-06-2011 |
20140088132 | CRYSTALLINE, ANHYDROUS FORMS OF OXYMORPHONE HYDROCHLORIDE - Crystalline, anhydrous hydrochloride salts of 4,5α-epoxy-3,14-dihydroxy-17-methylmorphinan-6-one (oxymorphone) are disclosed and three polymorphic forms of these salts are reported. The invention further relates to a method for the production of such salts, a pharmaceutical composition comprising an effective amount of such a salt and such a salt as a medicament and for the treatment and/or prevention of pain. | 03-27-2014 |
20150148368 | CRYSTALLINE, ANHYDROUS FORMS OF OXYMORPHONE HYDROCHLORIDE - Crystalline, anhydrous hydrochloride salts of 4,5α-epoxy-3,14-dihydroxy-17-methylmorphinan-6-one (oxymorphone) are disclosed and three polymorphic forms of these salts are reported. The invention further relates to a method for the production of such salts, a pharmaceutical composition comprising an effective amount of such a salt and such a salt as a medicament and for the treatment and/or prevention of pain. | 05-28-2015 |
Dagmar Pikas, Uppsala SE
Patent application number | Description | Published |
---|---|---|
20140364369 | USE OF CHEMICALLY MODIFIED HEPARIN DERIVATES IN SICKLE CELL DISEASE - The present invention relates to chemically modified heparin for use in the treatment of sickle cell disease, with an antifactor II activity of less than 10 IU/mg, an antifactor Xa activity of less than 10 IU/mg and an average molecular weight (Mw) between about 6.5 and 9.5 kDa. | 12-11-2014 |
Dagmar Preis-Amberger, Leverkusen DE
Patent application number | Description | Published |
---|---|---|
20120004328 | LILIAN SURROGATE - Due to toxicological concerns, it may be desirable to replace the fragrance compound lilial with less problematic compounds without losing the creative power and quality regarding perfumes. The present invention addresses this need by using selected oxazolidines described herein. | 01-05-2012 |
20120309669 | STABILIZED PERFUME OILS - Stable formulations and perfume compositions include amino alcohol(s) as well as >10 wt % fragrances. | 12-06-2012 |
20130017990 | LILIAL SURROGATE - Due to toxicological concerns, it may be desirable to replace the fragrance compound lilial with less problematic compounds without losing the creative power and quality regarding perfumes. The present invention addresses this need by using selected oxazolidines such as silvialoxazolidine described herein in conjunction with 1 or more additional scent components selected from a group of compounds such as methoxymelonal. | 01-17-2013 |
Dagmar Repschlaeger, Wiesloch DE
Patent application number | Description | Published |
---|---|---|
20100251096 | METHOD OF ENTERING OF DATA INTO A DATA PROCESSING SYSTEM - The present invention relates to a method of entering of data in a data processing system. A first linear sequence of top-level icons is displayed. A second linear sequence of second-level icons for a selected one of the top-level icons is also displayed such that the position of the leading icon of the second linear sequence is aligned with the selected one of the top-level icons of the first linear sequence. At least one data entry field for a selected one of the second-level icons is also displayed. | 09-30-2010 |
Dagmar Roth, Ludwigshafen DE
Patent application number | Description | Published |
---|---|---|
20100093587 | Detergent Composition and Method - An automatic dishwashing machine cleaning composition for use during one or more wash and/or rinse cycle(s) of the dishwashing machine, the composition having an alkaline pH and comprising at least one non-starch carbohydrase which exhibits activity at a pH of 8 or above. A method of using said composition is also disclosed. | 04-15-2010 |
Dagmar Salber, Aachen DE
Patent application number | Description | Published |
---|---|---|
20120074307 | METHOD AND DEVICE FOR CARRYING OUT A QUANTITATIVE SPATIALLY-RESOLVED LOCAL AND DISTRIBUITION ANALYSIS OF CHEMICAL ELEMENTS AND IN SITU CHARACTERIZATION OF THE ABLATED SURFACE REGIONS - A laser ablation chamber, which is suitable for use in a conventional laser-assisted micro dissection unit (LMD), in combination with the LMD allows for both quantitative spatially resolved nanolocal analysis and distribution analysis of element concentrations of a sample, and a microscopic detection of the surface topography of the same sample, in the nanometer range. Optionally, further examinations may follow, without having to remove the sample from a microscope slide bearing the sample. For the examination, a region of the sample to be analyzed is selected with the aid of a microscope of a LMD. For this purpose, the sample is located on the lower face of a cover slip (microscope slide), which also forms part of a laser ablation chamber mounted beneath the microscope slide and inside the LMD. A portion of the sample is ablated and analyzed. Optionally, the existing LMD instrumentation may be used to deliberately cut out certain regions of the tissue in which metals were detected for further analytics and to collect these regions in sample containers, which are mounted beneath the microscope slide after the laser ablation. | 03-29-2012 |
20130234015 | METHOD AND DEVICE FOR CARRYING OUT A QUANTITATIVE SPATIALLY RESOLVED LOCAL ANALYSIS AND DISTRIBUTION ANALYSIS OF CHEMICAL ELEMENTS AND IN SITU CHARACTERIZATION OF ABLATED SURFACE REGIONS - A laser ablation chamber, which is suitable for use in a conventional laser-assisted micro dissection unit (LMD), in combination with the LMD allows for both quantitative spatially resolved nanolocal analysis and distribution analysis of element concentrations of a sample, and a microscopic detection of the surface topography of the same sample, in the nanometer range. Optionally, further examinations may follow, without having to remove the sample from a microscope slide bearing the sample. For the examination, a region of the sample to be analyzed is selected with the aid of a microscope of a LMD. For this purpose, the sample is located on the lower face of a cover slip (microscope slide), which also forms part of a laser ablation chamber mounted beneath the microscope slide and inside the LMD. A portion of the sample is ablated and analyzed. Optionally, the existing LMD instrumentation may be used to deliberately cut out certain regions of the tissue in which metals were detected for further analytics and to collect these regions in sample containers, which are mounted beneath the microscope slide after the laser ablation. | 09-12-2013 |
Dagmar Scheel-Toellner, Birmingham GB
Patent application number | Description | Published |
---|---|---|
20150376701 | BIOMARKERS OF AUTOIMMUNE AND/OR CHRONIC DISEASES ASSOCIATED WITH JOINT INFLAMMATION - The present invention relates to methods and uses of FcRL4 expression and optionally RANKL expressing B cells as biomarkers and therapeutic target for treatment of an autoimmune and/or chronic diseases associated with joint inflammation, in particular Rheumatoid Arthritis (RA). | 12-31-2015 |
Dagmar Schlenzig, Halle/saale DE
Patent application number | Description | Published |
---|---|---|
20110152341 | CLEAVAGE OF B-AMYLOID PRECURSOR PROTEIN - Methods and means for the identification of meprin-α and meprin-β as novel β-secretases and antagonists thereof for use in the treatment of amyloidosis. | 06-23-2011 |
Dagmar Schopohl-König, Dresden DE
Patent application number | Description | Published |
---|---|---|
20110152506 | Method for Purifying Erythropoietin - The present invention relates to a method for preparing erythropoietin, wherein culture supernatant of erythropoietin-producing eukaryotic cells containing erythropoietin are subjected to the following steps: a) Removing the cell components; and b) treating the product from a) to the following chromatography steps in the sequence indicated i) reversed phase chromatography; ii) anion exchange chromatography; iii) hydroxyapatite chromatography. | 06-23-2011 |
20110189732 | Process for the Fermentative Production of Erythropoietin - The present invention relates to a process for the fermentative continuous production of erythropoietin, where eukaryotic erythropoietin-producing cells are cultured in a perfusion reactor while retaining the cells, the glucose concentration in the culture supernatant being adjusted via the perfusion rate and the cell number via the cell retention rate and/or the outward transferal of defined amounts of cell-containing culture medium from the bioreactor within preset zones. | 08-04-2011 |
Dagmar Schumacher, Heidelberg DE
Patent application number | Description | Published |
---|---|---|
20150037351 | NOVEL THERAPEUTIC TARGET FOR THE PREVENTION OF TUMOUR METASTASIS - The present invention relates to an inhibitor of the P2Y2 receptor or an inhibitor of the P2Y2 receptor signaling pathway for use in preventing the metastasis of tumours or as a lead compound for developing a drug for preventing the metastasis of tumours. | 02-05-2015 |
Dagmar Stahlhut-Behn, Dusseldorf DE
Patent application number | Description | Published |
---|---|---|
20120010310 | Macropore-Containing Polymer Foams As Insulation Materials - Polymer foams comprising macropores, the macropores having average cross sections of above 500 nm, are obtainable by reacting one or more epoxy resins with one or more amphiphilic epoxy resin hardeners in water in a phase inversion polymerization, where, during the phase inversion polymerization, but after phase inversion has taken place, a volume increase of the internal voids which form initially, and which are present predominantly as micropores having average cross sections of below 500 nm, is induced such that the fraction of the macropores—relative to the entirety of micropores and macropores present in the polymer foam—at the end of the phase inversion polymerization is above 50% by volume. Polymer foams of the present invention are suitable for use as acoustic insulation materials in means of transport and in industrial and plant construction. | 01-12-2012 |
20130062551 | Use Of Nanoporous Polymer Foams As Heat-Insulating Materials - Nanoporous polymer foams can be obtained by reacting one or more epoxy resins with one or more amphiphilic epoxy resin hardeners in water in a phase inversion polymerization process, with the stipulation that the binder fraction of the polymer foams is within the range of 15 to 39.9 wt %. Said nanoporous polymer foams are suitable as heat-insulating materials. | 03-14-2013 |
20130062552 | Composite Material - The invention relates to composite materials, containing (i) a nanoporous polymer foam, which can be obtained by reacting one or more epoxy resins with one or more amphiphilic epoxy resin hardeners in water in a phase inversion polymerization process, and (ii) one or more inorganic fillers and/or inorganic fibers, with the stipulation that hollow glass balls are excluded as fillers. Said composite materials are suitable as heat-insulating materials. | 03-14-2013 |
Dagmar Stahlhut-Behn, Erkrath DE
Patent application number | Description | Published |
---|---|---|
20110284160 | 2-Component Adhesives - The invention relates to 2-component adhesives comprising one or more epoxy resins as a first component (E) and one or more amphiphilic epoxy resin hardeners as a second component (H), wherein the first component (E) and the second component (H) are reacted in water in a phase inversion polymerization. | 11-24-2011 |
Dagmar Staroveska, Munchen DE
Patent application number | Description | Published |
---|---|---|
20080307002 | METHOD FOR PROVIDING AUDIO AND/OR VIDEO FILES - An audio and/or video file and method for providing audio and/or video files, wherein each audio and/or video file is subdivided in at least three parts, a first part of the audio and/or video file being provided in a first quality, a second part being provided in a second quality, additional information is provided in a third part, and the second quality being less than the first quality. | 12-11-2008 |
Dagmar Stolpmann, Bad Teinach-Zavelstein DE
Patent application number | Description | Published |
---|---|---|
20090148634 | Insert and Injection-Molded Part Having an Insert - An insert in an injection-molded part is provided, in particular a fastening bush for accommodating a fastening means in a receptacle opening, having at least one outer surface. At least the outer surface has a metallic anticorrosion layer on which a sealing layer is deposited. | 06-11-2009 |
Dagmar Wagenblasst, Porta Westfalica DE
Patent application number | Description | Published |
---|---|---|
20150274850 | METHOD FOR PRODUCING A POLYVINYL ACETATE DISPERSION - A method for producing an aqueous adhesive dispersion, wherein a dispersion is produced from a sheet silicate having an SiO | 10-01-2015 |
Dagmar Weber, Frankfurt Am Main DE
Patent application number | Description | Published |
---|---|---|
20150297296 | PACKAGING ASSEMBLY FOR DRUG DELIVERY DEVICES - A packaging assembly to accommodate at least two drug delivery devices is presented having an inner packaging to accommodate a first drug delivery device, and an outer packaging to accommodate a second drug delivery device and to accommodate the inner packaging. | 10-22-2015 |
Dagmar Wersing, Dresden DE
Patent application number | Description | Published |
---|---|---|
20090215079 | Method and Devices for the Detection of Microorganisms and/or the Activity Thereof - In a method for detection of microorganisms and/or their activity with biosensors, on a surface of a substrate over portions thereof at least one ligand for binding a receptor or at least one receptor for a ligand or at least one ligand for binding a receptor and at least one receptor for either the one or a further ligand are immobilized chemically, physically, or biologically, wherein physical or physicochemical changes, caused at receptors by binding of ligands that are emitted by microorganisms in the process of quorum sensing are measured. | 08-27-2009 |
20100285505 | Device and Method for Detecting a Substance by Means of Particle Plasmon Resonance (PPR) or Particle-Mediated Fluorescence Based on Cell Surface Polarizations - The invention relates to devices and methods for detecting a substance by cell surface polarizations and the detection thereof by means of PPR or particle-mediated fluorescence. The device for detecting a substance by cell surface polarization according to the invention has cells, wherein a gene the expression of which leads to the polarized presentation of a protein on the surface of the cell is placed under the control of a promotor which can be regulated by the substance to be detected, nanoparticles which are functionalized with a molecule which can bind specifically to the surface-exposed protein, and at least one optical measurement device, such that an accumulation of the nanoparticles on the surface of the cells can be detected by particle plasmon resonance or particle-mediated fluorescence. | 11-11-2010 |
Dagmar Windbiel, Essen DE
Patent application number | Description | Published |
---|---|---|
20090030097 | LINEAR POLYDIMETHYLSILOXANE-POLYOXYALKYLENE BLOCK COPOLYMERS LINKED VIA SIC GROUPS AND VIA CARBOXYLIC ESTER GROUPS, A PROCESS FOR PREPARING THEM AND THEIR USE - The invention provides linear polydimethylsiloxane-polyoxyalkylene block copolymers containing Si—C groups and carboxylic ester groups and having repeating (A | 01-29-2009 |
Dagmar Winkler, Filderstadt DE
Patent application number | Description | Published |
---|---|---|
20160074569 | Polymeric Whole Blood Hollow Fiber Membrane Filter Medium and Use Thereof For Separating Blood Plasma/Serum From Whole Blood - A whole blood hollow fiber membrane filter medium is made of a polymeric material having pores of a pore size that ensures permeability to blood plasma or serum but retains blood cells. The whole blood hollow fiber membrane filter medium is used for filtering a whole blood sample so that blood plasma or serum passes through the whole blood hollow fiber membrane filter medium and blood cells are retained. The obtained blood plasma shows no hemolysis. | 03-17-2016 |
20160096148 | CERAMIC WHOLE BLOOD HOLLOW FIBER MEMBRANE FILTER MEDIUM AND USE THEREOF FOR SEPARATIONG BLOOD PLASMA/SERUM FROM WHOLE BLOOD - A whole blood hollow fiber membrane filter medium is provided with a ceramic material having pores of a pore size that ensures permeability to blood plasma or serum and its molecular components while blood cells are retained. The whole blood hollow fiber membrane filter medium is used for separating blood plasma from whole blood, wherein the blood plasma preferably shows no hemolysis. | 04-07-2016 |
Dagmar Woelki, Hilden DE
Patent application number | Description | Published |
---|---|---|
20120301214 | Ball Joint - The invention relates to a ball joint which comprises a joint housing, a bearing shell received in the joint housing, and a ball stud having a ball head arranged for pivoting movement in the bearing shell. The ball head is prestressed by a spring system substantially in the direction of a longitudinal axis of the ball stud against the joint housing. The spring system is composed of spring elements connected in parallel and/or in series, at least one spring element of the spring system being made of a polymer material or of an elastomer material. | 11-29-2012 |
Dagmar Wótzel, Assling DE
Patent application number | Description | Published |
---|---|---|
20100030614 | Systems and Methods for Facilitating an Analysis of a Business Project - Systems and methods for analyzing projects in a business entity including multiple groups and multiple levels of decision making authority are provided. Project identification data that identifies a particular project is received. A project categorization of the project is performed to categorize the project based on one or more of the size, general risks, and complexity of the project. An anti-corruption risk assessment of the project is performed to categorize an anti-corruption risk associated with the project. A group-specific risk assessment of the project is performed to categorize a risk associated with the project relevant to one of the multiple groups of the business entity. A limit of authority escalation level is automatically determined based at least on the results of (a) the project categorization, (b) the anti-corruption risk assessment, and (c) the group-specific risk assessment, wherein the limit of authority escalation level indicates a particular level of decision making authority of the business entity required to approve the project. | 02-04-2010 |
Dagmar Wótzel, Assling DE
Patent application number | Description | Published |
---|---|---|
20100030614 | Systems and Methods for Facilitating an Analysis of a Business Project - Systems and methods for analyzing projects in a business entity including multiple groups and multiple levels of decision making authority are provided. Project identification data that identifies a particular project is received. A project categorization of the project is performed to categorize the project based on one or more of the size, general risks, and complexity of the project. An anti-corruption risk assessment of the project is performed to categorize an anti-corruption risk associated with the project. A group-specific risk assessment of the project is performed to categorize a risk associated with the project relevant to one of the multiple groups of the business entity. A limit of authority escalation level is automatically determined based at least on the results of (a) the project categorization, (b) the anti-corruption risk assessment, and (c) the group-specific risk assessment, wherein the limit of authority escalation level indicates a particular level of decision making authority of the business entity required to approve the project. | 02-04-2010 |
Dagmar Zweytick, Graz AT
Patent application number | Description | Published |
---|---|---|
20160045562 | Peptides for the Treatment of Cancer - The present invention relates to an isolated peptide for use in the treatment of cancer consisting of 12 to 50 amino acid residues comprising—at least two beta-strands, or—at least two alpha-helices or—at least one beta-strand and at least one alpha-helix, —wherein said beta-strands and/or alpha-helices are preferably separated from each other by at least one turn, wherein the peptide has a net positive charge of +7 or more; —wherein said peptide comprises at least one peptide moiety having amino acid sequence (X | 02-18-2016 |